Donald Jones

Donald Jones has extensive work experience as an advisor, board member, and co-founder in various companies. In 2023, they worked as an advisor at Edge Impulse and Hello Alpha, Inc. Donald has also served as an advisor at Sanguine, ISHI, Codex Health, Inc., Biolinq, and AstraZeneca since 2016. In 2020, they co-founded MYND Therapeutics Inc. and Tele911, where they also served as a board member and advisor. Additionally, Jones has been involved in the Digital Medicine Society (DiMe) as the IMPACT Co-Founder, Chair, and Virtual First Medical Practice Collaborative. The summary highlights their broad range of experience and expertise in the field.

Donald Jones attended UC San Diego from 1976 to 1981, where they obtained a Bachelor of Arts degree in Biology & Bio-Engineering. Donald then went on to attend the University of San Diego School of Law from 1981 to 1984, earning a Juris Doctor degree. Later, from 1989 to 1991, they pursued an MBA degree at the University of California, Irvine - The Paul Merage School of Business. No specific field of study was mentioned for their MBA.